Medicine and Dentistry
Neoplasm
100%
Hepatectomy
78%
Pancreaticoduodenectomy
72%
Surgery
62%
Breathing
56%
Carbon 13
56%
Pancreas Fistula
56%
Tricaprilin
56%
Recurrent Disease
46%
Artery
37%
Pancreas Cancer
37%
Malignant Neoplasm
37%
Surgeon
37%
Liver Metastasis
35%
Pancreatectomy
34%
Intraductal Papillary Mucinous Tumor
28%
Lymphadenitis
28%
Radiation Therapy
28%
Stapes
28%
Rectum Cancer
28%
COVID-19
28%
Tumor Thrombus
28%
Cancer Surgery
28%
Sigmoid Cancer
28%
Adjuvant Therapy
28%
Colon Cancer
28%
Pancreas Function
28%
Lithotomy
28%
Cancer
28%
Superior Mesenteric Artery
28%
Perioperative Period
28%
Pancreas Tumor
28%
Common Hepatic Artery
28%
Lenvatinib
28%
Hepatic Portal Vein
28%
Hepatocellular Carcinoma
28%
Plasma Cell Granuloma
28%
Mucinous Carcinoma
28%
Metastatic Carcinoma
28%
Lung Metastasis
21%
Adenocarcinoma
16%
Mucus
15%
Lymph Node
14%
Lymphadenopathy
14%
Cooperation
14%
FOLFOX
14%
Diagnosis
14%
Vein Embolism
14%
Computer Assisted Tomography
12%
Superior Mesenteric Vein
11%
Keyphrases
Pancreaticoduodenectomy
56%
Tumor
33%
Chemotherapy
28%
FOLFIRINOX
28%
Exocrine Function
28%
Paradoxical Results
28%
Gallbladder Cancer
28%
Metachronous Liver Metastasis
28%
Hepatic Artery Resection
28%
Stirrups
28%
Conversion Surgery
28%
Pancreatic Colloid Carcinoma
28%
Histological Remission
28%
Hepatectomy
28%
Radiation Therapy
28%
Pancreatic Fistula
28%
Rehepatectomy
28%
Hepatic Artery
28%
Superior Mesenteric Artery
28%
Resectable Pancreatic Cancer
28%
Marginal Livers
28%
Intracholecystic Papillary Neoplasm
28%
Breath Test
28%
Left Hepatic Artery
18%
Arterial Blood Flow
14%
Indocyanine Green Clearance
14%
Chief Complaint
14%
Venous Embolism
10%
Upper Abdominal Pain
9%
Right Hepatic Artery
9%
Hepatic Inflammatory Pseudotumor
9%
Stepwise Strategy
9%
Carbohydrate Antigen 19-9 (CA19-9)
9%
R0 Resection
9%
Pancreatic Cancer
9%
Acuity Scale
9%
Contrast-enhanced CT Scan
9%
Common Hepatic Artery
9%
Local Control
9%
Modified FOLFIRINOX
9%
Jaundice
9%
Partial Response
9%
Treatment Effect
9%
Uncinate
9%
Positional Relationship
9%
Initial Treatment
9%
Jejunal Artery
9%
Response Evaluation Criteria in Solid Tumors (RECIST)
9%
Abdomen
9%
Am(III)
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Metastasis
56%
Pancreas Fistula
56%
Tricaprilin
56%
Carbon 13
56%
Chemotherapy
42%
Gallbladder Cancer
28%
Sigmoid Cancer
28%
Pancreas Tumor
28%
Remission
28%
Pandemic
28%
Recurrent Disease
26%
Malignant Neoplasm
14%
Bevacizumab
9%
Pancreas Cancer
9%
Gemcitabine
7%
Cisplatin
7%
Combination Therapy
7%
Cancer Chemotherapy
7%
Phenmetrazine
7%
Fluoropyrimidine Derivative
7%
Bladder Tumor
7%
Chemotherapy Regimens
7%
Pancreas Adenocarcinoma
5%